secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K/A
Filed at:   2024-04-24T23:59:59+00:00
Accession:  0001731122-24-000681
Event type: other_material
Sentiment:  negative
Materiality: 0.55
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renovaro Cube audited: €2.1M net loss post-acquisition, going concern noted
---------------------------------------------------------------------------

- Successor period (Aug 24–Dec 31, 2023) net loss of €2,100,579, no revenue generated.
- Accumulated deficit of €2,100,579; cash only €114,520 at Dec 31, 2023.
- Auditor includes going-concern explanatory paragraph citing negative operating cash flows and deficit.
- Predecessor (Grace Systems) net loss €129,572 for Jan 1–Aug 23, 2023 and €623,982 for FY 2022.
- Acquisition of Grace Systems by Renovaro Cube treated as asset acquisition; company in development stage.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112224000681/0001731122-24-000681-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112224000681/e5613_8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001731122-24-000681

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer